Sugi Predict

Sugi Predict / Compounds / SCHEMBL3736932

SCHEMBL3736932

SCHEMBL3736932

CCCCCCCCCCCCCCCCC(O)C(=O)OCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CETP P11597 3/20 0.52
▸ ALDH1A1 P00352 3/20 0.51
▸ CYP3A4 P08684 1/20 0.51
▸ TSHR P16473 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ TDP1 Q9NUW8 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ GPR84 Q9NQS5 3/20 0.50
▸ FFAR1 O14842 1/20 0.50
▸ CSNK1E P49674 1/20 0.49
▸ SIRT2 Q8IXJ6 2/20 0.48
▸ SIRT1 Q96EB6 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ CNR2 P34972 1/20 0.48
▸ SIRT3 Q9NTG7 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7305728 1.00 CETP (0.52) CETPALDH1A1CYP3A4TSHRMAPK1
SCHEMBL7305733 1.00 CETP (0.52) CETPALDH1A1CYP3A4TSHRMAPK1
SCHEMBL27424922 1.00 CETP (0.52) CETPALDH1A1CYP3A4TSHRMAPK1
SCHEMBL21245794 1.00 CETP (0.52) CETPALDH1A1CYP3A4TSHRMAPK1
SCHEMBL2677628 1.00 CETP (0.52) CETPALDH1A1CYP3A4TSHRMAPK1
SCHEMBL16648466 1.00 CETP (0.52) CETPALDH1A1CYP3A4TSHRMAPK1
SCHEMBL16648564 0.98 ALDH1A1 (0.52) CETPALDH1A1CYP3A4TSHRMAPK1
SCHEMBL16648567 0.98 ALDH1A1 (0.52) CETPALDH1A1CYP3A4TSHRMAPK1
SCHEMBL30759387 0.94 ALDH1A1 (0.54) CETPALDH1A1CYP3A4TSHRMAPK1
SCHEMBL6869938 0.94 ALDH1A1 (0.54) CETPALDH1A1CYP3A4TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117062533-A Edible barrier film compositions 阿比尔技术公司 2023-11-14 — — CN disclosed
US-20220312803-A1 EDIBLE BARRIER FILM COMPOSITION APEEL TECHNOLOGY, INC. 2022-10-06 — — US disclosed
US-7825238-B2 Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine MEDIVIR AB (SE) 2010-11-02 — — US disclosed
CN-100460417-C Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the DNA polymerase MEDIVIR AB HUDDINGE (SE) 2009-02-11 — — CN disclosed
CN-1872869-A Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the DNA polymerase MEDIVIR AB HUDDINGE (SE) 2006-12-06 — — CN disclosed
CN-1286845-C Nucleoside analogs as antiviral agents for retroviral reverse transcriptase and DNA polymerase inhibitors MEDIVIR AB (SE) 2006-11-29 — — CN disclosed
US-7071173-B2 Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine MEDIVIR AB (SE) 2006-07-04 — — US disclosed
US-20060122383-A1 Antiviral methods employing double esters of 2', 3'-dideoxy-3'-fluoroguanosine MEDIVIR AB (SE) 2006-06-08 — — US disclosed
US-20060058259-A1 ANTIVIRAL METHODS EMPLOYING DOUBLE ESTERS OF 2', 3'-DIDEOXY-3'-FLUOROGUANOSINE MEDIVIR AB (SE) 2006-03-16 — — US disclosed
US-6974802-B2 Treatment of viral infections using prodrugs of 2′,3-dideoxy,3′-fluoroguanosine MEDIVIR AB (SE) 2005-12-13 — — US disclosed
US-4708719-A NONAQUEOUS SYSTEMS FOR THERMOPLASTIC MATERIALS; ADDING VARIOUS CYCLOALIPHATIC AND AROMATIC ESTERS CRUCIBLE CHEMICAL COMPANY (US) 1987-11-24 — — US disclosed
US-4661117-A MONO-, DI-, AND TRI-AROMATIC ESTERS, ALKOXYLATED ALKYLPHENOLS OR ESTERS, DISPERSE DYES CRUCIBLE CHEMICAL COMPANY (US) 1987-04-28 — — US disclosed
US-4609375-A HIGH-BOIL-NG AROMATIC ESTER SOLVENT CRUCIBLE CHEMICAL COMPANY (US) 1986-09-02 — — US disclosed
EP-0124606-A4 WATERLESS DIP DYE COMPOSITION AND METHOD OF USE THEREOF FOR TEXTILE-RELATED MATERIALS. WILSON ROBERT B (US) 1985-09-18 — — EP disclosed
EP-0126752-A4 WATERLESS DIP DYE COMPOSITION AND METHOD OF USE THEREOF FOR SYNTHETIC ARTICLES. WILSON ROBERT B (US) 1985-09-16 — — EP disclosed
EP-0126752-A1 WATERLESS DIP DYE COMPOSITION AND METHOD OF USE THEREOF FOR SYNTHETIC ARTICLES WILSON, Robert Buchanan (US) 1984-12-05 — — EP disclosed
EP-0124606-A1 WATERLESS DIP DYE COMPOSITION AND METHOD OF USE THEREOF FOR TEXTILE-RELATED MATERIALS WILSON, Robert Buchanan (US) 1984-11-14 — — EP disclosed
WO-1984001971-A1 WATERLESS DIP DYE COMPOSITION AND METHOD OF USE THEREOF FOR SYNTHETIC ARTICLES WILSON ROBERT B 1984-05-24 — — WO disclosed
WO-1984001972-A1 WATERLESS DIP DYE COMPOSITION AND METHOD OF USE THEREOF FOR TEXTILE-RELATED MATERIALS WILSON ROBERT B 1984-05-24 — — WO disclosed
US-4394126-A DISPERSANTS, EMULSIFIERS ATOCHEM NORTH AMERICA, INC. 1983-07-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060058259-A1 ANTIVIRAL METHODS EMPLOYING DOUBLE ESTERS OF 2', 3'-DIDEOXY-3'-FLUOROGUANOSINE UNG, HAVCR2, EIF2AK2 CETP 674/4885ALDH1A1 1605/4885CYP3A4 313/4885
US-20060122383-A1 Antiviral methods employing double esters of 2', 3'-dideoxy-3'-fluoroguanosine UNG, HAVCR2, EIF2AK2 CETP 674/4885ALDH1A1 1605/4885CYP3A4 313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.